Clinical Trials in Atlanta

Showing 14661-14680 of 19,805 trials

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

NCT01122901

This phase II trial is studying how well gamma-secretase/Notch signalling pathway inhibitor RO4929097 works in treating patients with recurrent or progressive glioblastoma. Gamma-secretase/Notch signalling pathway inhibitor RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)47 participantsStarted Dec 2010

Atlanta, Georgia, United States • Detroit, Michigan, United States • Cleveland, Ohio, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

NCT00530816

To evaluate the best overall response rate, safety and tolerability of carfilzomib in patients with relapsed or refractory multiple myeloma.

Multiple Myeloma

Amgen164 participantsStarted Sep 2007

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Laguna Hills, California, United States +27 more locations

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Find Trials by Condition in Atlanta

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Discovery Elbow Long-Term Survivorship

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects